about
Heightened stress response in primary fibroblasts expressing mutant eIF2B genes from CACH/VWM leukodystrophy patientsThe Apc5 subunit of the anaphase-promoting complex/cyclosome interacts with poly(A) binding protein and represses internal ribosome entry site-mediated translationLow efficiency of the 5' nontranslated region of hepatitis A virus RNA in directing cap-independent translation in permissive monkey kidney cellsPoor cerebral inflammatory response in eIF2B knock-in mice: implications for the aetiology of vanishing white matter diseaseTransgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndromeChildhood ataxia with CNS hypomyelination/vanishing white matter disease--a common leukodystrophy caused by abnormal control of protein synthesis.Transcription-coupled translation control of AML1/RUNX1 is mediated by cap- and internal ribosome entry site-dependent mechanisms.A point mutation in translation initiation factor eIF2B leads to function--and time-specific changes in brain gene expression.Species-specific microRNA roles elucidated following astrocyte activation.Cleavage of the HIV replication primer tRNALys,3 in human cells expressing bacterial anticodon nucleaseUncovering Hidden Layers of Cell Cycle Regulation through Integrative Multi-omic AnalysisProteomics-level analysis of myelin formation and regeneration in a mouse model for Vanishing White Matter disease.PUNCH-P for global translatome profiling: Methodology, insights and comparison to other techniques.A point mutation in translation initiation factor 2B leads to a continuous hyper stress state in oligodendroglial-derived cells.Regulation of mRNA Translation during cellular division.Novel proteomic approach (PUNCH-P) reveals cell cycle-specific fluctuations in mRNA translation.Dicodon monitoring of protein synthesis (DiCoMPS) reveals levels of synthesis of a viral protein in single cellsMutant eIF2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease.Diverse poly(A) binding proteins mediate internal translational initiation by a plant viral IRES.Gene expression using the vaccinia virus/ T7 RNA polymerase hybrid system.Ribosomal slowdown mediates translational arrest during cellular division.Characterization and molecular cloning of a novel MUC1 protein, devoid of tandem repeats, expressed in human breast cancer tissue.Analysis of hepatitis A virus translation in a T7 polymerase-expressing cell line.Cell-specific posttranslational events affect functional expression at the plasma membrane but not tetrodotoxin sensitivity of the rat brain IIA sodium channel alpha-subunit expressed in mammalian cells.Overexpression of human glucocerebrosidase containing different-sized leaders.Mitotic modulation of translation elongation factor 1 leads to hindered tRNA delivery to ribosomes.Proteomic analysis of polyribosomes identifies splicing factors as potential regulators of translation during mitosis.New ways of initiating translation in eukaryotes.Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins. Cytokine receptor-like molecules.Phosphorylation of initiation factor-2 alpha is required for activation of internal translation initiation during cell differentiation.Monitoring Protein Synthesis in Living Cells with Fluorescent Labeled tRNA FRET Pairs.Mitochondrial malfunction in vanishing white matter disease: a disease of the cytosolic translation machinery.A Unique ISR Program Determines Cellular Responses to Chronic Stress.Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription.Does EBV RNA modulate ADA mRNA translation?Drug Screening Identifies Sigma-1-Receptor as a Target for the Therapy of VWM LeukodystrophyA mouse model for eukaryotic translation initiation factor 2B-leucodystrophy reveals abnormal development of brain white matterMolecular structure and expression of the gene locus on chromosome 21 encoding the Cu/Zn superoxide dismutase and its relevance to Down syndromeImpaired neurotransmitter uptake in PC12 cells overexpressing human Cu/Zn-superoxide dismutase--implication for gene dosage effects in Down syndromeMolecular genetics of Down's syndrome: overexpression of transfected human Cu/Zn-superoxide dismutase gene and the consequent physiological changes
P50
Q24309616-94026C50-B3A0-4694-B799-4C1CFC926829Q24623530-3E6ADD6C-9641-4D0D-A2F8-9BE8FA47D127Q24648082-F89DB508-F5CE-4680-8383-3D379D239ADDQ28389410-08436B23-ADC6-4189-B3B8-07393A39CA1BQ28592168-5C45C963-7A17-4704-B235-075C77A75695Q31027652-22103F3E-A700-477F-A068-6F45DF7796A8Q33962440-0BF2F4B9-65EC-4E03-B9E9-1E920A18E71FQ34071458-29B0C814-996A-4830-9266-F908927243B6Q34159796-2B59EF36-F6C6-4768-AB3D-5D2CF93AA412Q34751283-668EC353-FB86-410E-95A8-BD3E2A88060BQ35800525-A656E42E-ECF0-447B-BD59-7BAB6CC71A77Q35843362-BD45693D-8E2A-4389-835C-66233CCED5BEQ36477534-636AFA0F-315B-4416-B08A-B986CD527777Q36972922-3CB83E8C-3A8B-4162-90C6-58C754E3C5F4Q37073508-AA18C5BA-7437-4E9D-8335-7B5BDA532E9EQ37138596-86383FB8-556D-4F0E-A66A-E4E7A2247B91Q37224776-2E9D785B-EB3A-4F71-9177-4F16CA10A7F3Q38901362-1C17C413-3171-455C-A2FE-4A378C391467Q39841626-6F43FCD0-540B-4F0B-8C7A-86F68D2E1E47Q39989589-A962A4C6-62D7-4065-857C-76DD53164C35Q40100414-3DBDC76F-1E43-477A-BD9D-1FEF36CCCBAAQ41444956-E185FBE0-739C-4756-9E40-0684F79DF2D3Q41500887-F7DBF107-FC0B-4C21-B8AF-45BB779F73C6Q41651529-94AC16E3-2D6E-452E-9805-6E2C958172A7Q41982668-3BFA3C7C-5397-48B4-8F35-289530C19E46Q42148482-D3E9B172-FEB5-4943-95DB-D2AC62D42816Q42237199-965FD952-2244-4084-B6C0-1F02870E5CC7Q42738018-815E0D49-2B26-45F0-9FB4-DA5456388E4CQ42831894-6FE938A1-1B00-4928-B667-CDB0D2A381DCQ43464110-136181F4-53B1-42DE-A959-2AD5138861BEQ46509442-FE6F8191-D695-4EA9-BDCA-3724FE508A91Q47140617-17191EC6-3F13-411B-B502-53AD74CEE64BQ47315154-FAED5789-C073-4040-A59E-9CC35770D779Q47801872-45450260-E3E0-434E-B2C2-68F2E3684CB6Q48039331-78090BA7-01F6-437B-929A-D38BEEDB7000Q57073756-B4346737-F326-458C-94F6-21E81E0BF598Q57185560-D4FE599B-BC3D-4B56-B84D-B6CAEFFC1CC7Q67297406-8DA15EE5-7609-4405-9134-69BFB8E5BD0EQ69913258-807CBCEB-8E4F-4114-BDC1-A00139340835Q70029840-CED6D89E-99E2-405E-8F24-FE942E2740F9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Orna Elroy-Stein
@ast
Orna Elroy-Stein
@en
Orna Elroy-Stein
@es
Orna Elroy-Stein
@nl
type
label
Orna Elroy-Stein
@ast
Orna Elroy-Stein
@en
Orna Elroy-Stein
@es
Orna Elroy-Stein
@nl
prefLabel
Orna Elroy-Stein
@ast
Orna Elroy-Stein
@en
Orna Elroy-Stein
@es
Orna Elroy-Stein
@nl
P106
P31
P496
0000-0002-3716-1540